Cargando…
SRT1720 Alleviates ANIT-Induced Cholestasis in a Mouse Model
Intrahepatic cholestasis is a kind of clinical syndrome along with hepatotoxicity which caused by intrahepatic and systemic accumulations of bile acid. There are several crucial generating factors of the pathogenesis of cholestasis, such as inflammation, dysregulation of bile acid transporters and o...
Autores principales: | Yu, Linxi, Liu, Xiaoxin, Yuan, Zihang, Li, Xiaojiaoyang, Yang, Hang, Yuan, Ziqiao, Sun, Lixin, Zhang, Luyong, Jiang, Zhengzhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425580/ https://www.ncbi.nlm.nih.gov/pubmed/28553227 http://dx.doi.org/10.3389/fphar.2017.00256 |
Ejemplares similares
-
Mechanism of crocin I on ANIT-induced intrahepatic cholestasis by combined metabolomics and transcriptomics
por: Song, Dandan, et al.
Publicado: (2023) -
Dioscin Protects ANIT-Induced Intrahepatic Cholestasis Through Regulating Transporters, Apoptosis and Oxidative Stress
por: Yao, Hong, et al.
Publicado: (2017) -
The sirtuin 1 activator SRT1720 alleviated endotoxin-induced fulminant hepatitis in mice
por: Zhou, Dan, et al.
Publicado: (2021) -
SRT1720 as an SIRT1 activator for alleviating paraquat-induced models of Parkinson's disease
por: Chao, Chih-Chang, et al.
Publicado: (2022) -
SRT1720 improves survival and healthspan of obese mice
por: Minor, Robin K., et al.
Publicado: (2011)